))
Reframing Thyroid Cancer: Precision, Progress & Personalized Care
Manage episode 505871825 series 3393216
Baptist Health에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Baptist Health 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Why do thyroid cancers demand a more nuanced approach, despite high survival rates?
In this episode of Doc to Doc, Dr. Meghan Crawley, head and neck surgical oncologist at Miami Cancer Institute, joins Dr. Rachel Slotcavage, endocrine surgeon at Lynn Cancer Institute, to explore what makes thyroid cancers so unique and how treatment approaches are evolving.
From surgery and RAI therapy to targeted therapies, immunotherapy, and biomarker-driven decisions, this conversation takes a closer look at how precision medicine is shaping the future of thyroid cancer care—and what every clinician should consider in today’s multidisciplinary landscape.
Meghan Crawley, M.D.
Head and Neck Surgical Oncologist with Baptist Health Miami Cancer Institute
Rachel Slotcavage, M.D.
Endocrine surgeon with the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital
32 에피소드
공유
